ZYNE | CNA Finance

Home Tags ZYNE

Cannabis Stocks

Zynerba Pharmaceuticals (ZYNE) Stock: Climbing On Patent News

Joshua Rodriguez - February 26, 2019

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) is having an incredibly strong start to the trading session this morning, and for good reason. The cannabis biotech...

Archived Articles

Zynerba Pharmaceuticals (ZYNE) Stock: Falling Hard On Offering

Joshua Rodriguez - July 20, 2018

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) is having an incredibly rough start to the trading session this morning, and for good reason. The company announced...

Archived Articles

Zynebra Pharmaceuticals (ZYNE) Stock: Falling Hard On Failed Study

Joshua Rodriguez - August 7, 2017

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) is having an overwhelmingly rough start to the trading session in the pre-market hours this morning, and for good...

Biotech Stocks

Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib

Joshua Rodriguez - February 20, 2019

We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies...

Midatech Pharma (MTP) Stock: Here’s Why It’s Flying!

February 26, 2019

How to Sell Your Car if it Doesn’t Run

October 9, 2014

Reviews

TradeMiner Review: Is It Worth Your While?

Joshua Rodriguez - February 20, 2019

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...

Trade Ideas Review: A Deep Dive Into What They Have To...

February 20, 2019

Tradespoon Review: Is The Service Worth Your Money?

February 20, 2019

TradeKing Review 2015 – Read This Before Signing Up

February 20, 2019

Disclaimer- CNA Finance is NOT an Investment Advisor. Our goal is to bring both news and under discovered stocks to the attention of investors to assist in making smart decisions in the market. CNA Finance is a for profit company. That profit is generated through three (3) different types of relationships. First and foremost, we work with pay per click and CPM advertisers on banners. We also have affiliate relationships with various companies where we earn a portion of the sales revenue that we refer. Finally, we may have relationships with some of the companies or IR firms that represent companies mentioned within our works in which we are compensated in cash and or stock for consulting, investor relations, and Press Release services (click here for details). Therefore, while we do everything in our power to provide true, well-researched, and well-thought out opinions, in some instances, a potential conflict of interest may exist. CNA Finance encourages all investors to seek professional advice before making any investment decision.

Tag: ZYNE

Reviews